Hans Hull

(Mr. Hans Hull J.D.)

Currently holds a position at Pliant Therapeutics Inc

Positions

Position Company Period
Chief Business Officer Pliant Therapeutics Inc None -
Senior Vice President - Business Operations Adverum Biotechnologies Inc Dec. 9, 2015 - Feb. 12, 2016
Interim President and Chief Executive Officer Adverum Biotechnologies Inc July 23, 2015 - Dec. 9, 2015
Senior Vice President - Legal and Corporate Development Adverum Biotechnologies Inc July 1, 2014 - July 23, 2015
Vice President of Legal and Corporate Development Adverum Biotechnologies Inc Jan. 1, 2011 - July 1, 2014
Hans Hull's trades of Pliant Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-22 2025-01-17
PS Planned sale
15,936 -7.0%
11.20
USD 178,501 		15,936 -7.0% 11.20 USD 178,501
2024-07-12 2024-07-10
PS Planned sale
9,900 -4.2%
11.56
USD 114,444 		9,900 -4.2% 11.56 USD 114,444
2024-01-19 2024-01-17
PS Planned sale
9,786 -5.0%
17.23
USD 168,613 		9,786 -5.0% 17.23 USD 168,613
2023-08-07 2023-08-04
PS Planned sale
20,050 -9.3%
20.01
USD 401,201 		20,050 -9.3% 20.01 USD 401,201
2023-08-07 2023-08-03
PS Planned sale
13,069 -6.0%
20.00
USD 261,380 		13,069 -6.0% 20.00 USD 261,380
2023-07-19 2023-07-17
PS Planned sale
17,937 -7.6%
18.01
USD 323,029 		17,937 -7.6% 18.01 USD 323,029
2023-04-03 2023-03-30
PS Planned sale
9,036 -4.3%
26.52
USD 239,643 		9,036 -4.3% 26.52 USD 239,643
2022-12-21 2022-12-20
S Sale
8,748 -6.0%
19.10
USD 167,108 		8,748 -6.0% 19.10 USD 167,108
// ... existing code ... // ... rest of the file ...